Te‐Chun Hsia

9.5k citations
131 papers · 4.2k indexed · h-index 35

Te‐Chun Hsia

128 papers receiving 4.1k citations

Peers

Te‐Chun Hsia
Comparison fields: 5 of 129
  • Critical Care and Intensive Care Medicine 261
  • Toxicology 167
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.4k
  • Cancer Research 570
Replace Li Lin with:
Li Lin China
David W. McFadden United States
Wilbert H.M. Peters Netherlands
Bruno Lacarelle France
Satoshi Endo Japan
Junichi Hasegawa Japan
Xia Wang China
Yi Chen China
Antonella Marino Italy
In‐Jin Jang South Korea
Te‐Chun Hsia relative to Li Lin China Li Lin's profile →
Citations per field
00.5×3.2×
Li Lin · 1×
Citations per year

Countries citing papers authored by Te‐Chun Hsia

Since Specialization
Citations

This map shows the geographic impact of Te‐Chun Hsia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Chun Hsia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Chun Hsia more than expected).

Fields of papers citing papers by Te‐Chun Hsia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te‐Chun Hsia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Chun Hsia. The network helps show where Te‐Chun Hsia may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Te‐Chun Hsia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Te‐Chun Hsia Line = papers co-authored together Te‐Chun Hsia links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20233
3 20231
4 2019282
5 201960
6 201621
7 201627
8 201532
9 201524
10 201334
11 201361
12
Association of DNA double-strand break gene XRCC6 genotypes and lung cancer in Taiwan.
201215
13 201121
14 20109
15 201026
16 2010188
17 200935
18 2008108
19 200723
20 200736

About Te‐Chun Hsia

Te‐Chun Hsia is a scholar working on Toxicology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 131 papers that have together received 4.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Research Studies (18 papers), Bioactive Compounds and Antitumor Agents (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Pleural and Pulmonary Diseases (9 papers), Ultrasound in Clinical Applications (7 papers) and Asthma and respiratory diseases (7 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (261 citations), Toxicology (167 citations) and Oncology (1.2k citations). Te‐Chun Hsia has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jing‐Gung Chung, Chih‐Yen Tu, Jai‐Sing Yang, Wu-Huei Hsu, Chuen-Ming Shih, Chia‐Hung Chen, Hung‐Jen Chen, Hsu-Feng Lu, Wei‐Chih Liao and Hsiu‐Maan Kuo. Their work appears in journals such as Journal of Thoracic Oncology, Anticancer Research, PLoS ONE, Environmental Toxicology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026